BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 28479239)

  • 1. Renal Mass and Localized Renal Cancer: AUA Guideline.
    Campbell S; Uzzo RG; Allaf ME; Bass EB; Cadeddu JA; Chang A; Clark PE; Davis BJ; Derweesh IH; Giambarresi L; Gervais DA; Hu SL; Lane BR; Leibovich BC; Pierorazio PM
    J Urol; 2017 Sep; 198(3):520-529. PubMed ID: 28479239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I.
    Campbell SC; Clark PE; Chang SS; Karam JA; Souter L; Uzzo RG
    J Urol; 2021 Aug; 206(2):199-208. PubMed ID: 34115547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II.
    Campbell SC; Uzzo RG; Karam JA; Chang SS; Clark PE; Souter L
    J Urol; 2021 Aug; 206(2):209-218. PubMed ID: 34115531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2017 AUA Renal Mass and Localized Renal Cancer Guidelines: Imaging Implications.
    Ward RD; Tanaka H; Campbell SC; Remer EM
    Radiographics; 2018; 38(7):2021-2033. PubMed ID: 30339517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
    Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
    BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does renal mass biopsy influence multidisciplinary treatment recommendations?
    Lobo JM; Clements MB; Bitner DP; Mikula MD; Noona SW; Sultan MI; Cathro HP; Lambert DL; Schenkman NS; Krupski TL
    Scand J Urol; 2020 Feb; 54(1):27-32. PubMed ID: 31868063
    [No Abstract]   [Full Text] [Related]  

  • 7. How Does Treatment Uncertainty Factor into Decisions to Place Patients on Active Surveillance for Kidney Cancer?
    Cheaib JG; Pierorazio PM
    Eur Urol Focus; 2019 Nov; 5(6):946-948. PubMed ID: 31351899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaborative Review: Factors Influencing Treatment Decisions for Patients with a Localized Solid Renal Mass.
    Chandrasekar T; Boorjian SA; Capitanio U; Gershman B; Mir MC; Kutikov A
    Eur Urol; 2021 Nov; 80(5):575-588. PubMed ID: 33558091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving practice patterns for the management of small renal masses in the USA.
    Yang G; Villalta JD; Meng MV; Whitson JM
    BJU Int; 2012 Oct; 110(8):1156-61. PubMed ID: 22372984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small renal masses: toward more rational treatment.
    Thomas AA; Campbell SC
    Cleve Clin J Med; 2011 Aug; 78(8):539-47. PubMed ID: 21807926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active Surveillance in Small Renal Masses in the Elderly: A Literature Review.
    Cheung DC; Finelli A
    Eur Urol Focus; 2017 Oct; 3(4-5):340-351. PubMed ID: 29175368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active Surveillance is Superior to Radical Nephrectomy and Equivalent to Partial Nephrectomy for Preserving Renal Function in Patients with Small Renal Masses: Results from the DISSRM Registry.
    Danzig MR; Ghandour RA; Chang P; Wagner AA; Pierorazio PM; Allaf ME; McKiernan JM
    J Urol; 2015 Oct; 194(4):903-9. PubMed ID: 25813449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-Analysis.
    Pierorazio PM; Johnson MH; Patel HD; Sozio SM; Sharma R; Iyoha E; Bass EB; Allaf ME
    J Urol; 2016 Oct; 196(4):989-99. PubMed ID: 27157369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the Diagnosis and Management of Renal Angiomyolipoma.
    Flum AS; Hamoui N; Said MA; Yang XJ; Casalino DD; McGuire BB; Perry KT; Nadler RB
    J Urol; 2016 Apr; 195(4 Pt 1):834-46. PubMed ID: 26612197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
    Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ
    Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic Renal Cell Carcinoma: A Report on Outcomes of Surgery and Active Surveillance in Patients Retrospectively Identified on Pretreatment Imaging.
    Kashan M; Ghanaat M; Hötker AM; Duzgol C; Sanchez A; DiNatale RG; Blum KA; Becerra MF; Manley BJ; Casuscelli J; Chiok M; Coleman JA; Russo P; Tickoo SK; Akin O; Hakimi AA
    J Urol; 2018 Aug; 200(2):275-282. PubMed ID: 29496470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Analysis of Surgery, Thermal Ablation, and Active Surveillance for Renal Oncocytic Neoplasms.
    Miller BL; Mankowski Gettle L; Van Roo JR; Ziemlewicz TJ; Best SL; Wells SA; Lubner MG; Hinshaw JL; Lee FT; Nakada SY; Huang W; Abel EJ
    Urology; 2018 Feb; 112():92-97. PubMed ID: 29030073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Novel Scoring System Quantifies Opportunities to Reduce Surgery for Benign Renal Neoplasms: A Retrospective Quality Improvement Analysis within the MUSIC-KIDNEY Collaborative.
    Peabody H; Patel A; Johnson A; Mirza M; Noyes SL; Schervish E; Kaul S; Rogers CG; Lane BR; Semerjian A
    J Urol; 2020 Dec; 204(6):1160-1165. PubMed ID: 32628102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry.
    Pierorazio PM; Johnson MH; Ball MW; Gorin MA; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME
    Eur Urol; 2015 Sep; 68(3):408-15. PubMed ID: 25698065
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 40.